CTT Pharmaceutical Holdings, Inc.
OTCPKCTT Pharmaceutical Holdings heads into its May 22 earnings date with a regulatory filing on the table and a CEO who hasn't stopped adding to his position. The most telling signal this week is the S-1/A amendment filed with the SEC on April 15. That registration statement update coincided with a one-day drop of 12.5% in the stock — which then recovered 7.6% over the following…
Snapshot as of 9 May 2026
CTT Pharmaceutical Holdings heads into its May 22 earnings date with a regulatory filing on the table and a CEO who hasn't stopped adding to his position. The most telling signal this week is the S-1/A amendment filed…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CTTH — free to start on ORTEX.
Sign up for free →Open CTTH on ORTEX